Association of FMR1 repeat size with ovarian dysfunction.
about
Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)Transcription factor FIGLA is mutated in patients with premature ovarian failureFragile X syndrome: the FMR1 CGG repeat distribution among world populationsAdvances in the treatment of fragile X syndromeContemporary genetic technologies and female reproductionNOBOX homeobox mutation causes premature ovarian failureFragile X spectrum disordersUnstable mutations in the FMR1 gene and the phenotypesRepeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disordersThe unstable repeats--three evolving faces of neurological diseaseThe FMR1 gene, infertility, and reproductive decision-making: a reviewStudy of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 GeneThe role of AGG interruptions in the transcription of FMR1 premutation allelesA clinical research integration special program (CRISP) for young women with primary ovarian insufficiencyFMR1 CGG Repeats: Reference Levels and Race-Ethnic Variation in Women With Normal Fertility (Study of Women's Health Across the Nation).Fragile X: leading the way for targeted treatments in autism.CGG repeat in the FMR1 gene: size mattersOvarian dysfunction and FMR1 alleles in a large Italian family with POF and FRAXA disorders: case reportA review of fragile X premutation disorders: expanding the psychiatric perspectiveFragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatmentMethylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio.Fibroblast phenotype in male carriers of FMR1 premutation allelesCGG allele size somatic mosaicism and methylation in FMR1 premutation alleles.Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxiety.Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome.Broad clinical involvement in a family affected by the fragile X premutation.Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriersPathogenesis and causes of premature ovarian failure: an update.FMR1 CGG allele size and prevalence ascertained through newborn screening in the United StatesIntermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age.Biomarkers in the Study of Families of Individuals with Developmental Disabilities.A Variance-Component Framework for Pedigree Analysis of Continuous and Categorical Outcomes.Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers.Advances in understanding the molecular basis of FXTASFragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.FMR1 premutation is an uncommon explanation for premature ovarian failure in Han Chinese.FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles.Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion.Associated features in females with an FMR1 premutation
P2860
Q21198724-95D9303E-8EEC-46BE-84A0-BAA6CBA0598EQ21710713-EADA2320-8FEE-4503-B4D0-C9913CCDE9D2Q24629837-93F0EFB6-4BED-41F5-9DF8-A040F924D682Q24632814-C2DBA57F-3A5B-4481-80EA-11B6990135A6Q24635098-9DC2593C-7E18-4DA7-9AE6-210716DF05AEQ24677575-8E78170E-550B-4FD5-9872-A41A0A737613Q26824376-D55011AF-2591-4535-8535-494689347206Q26996649-0D4C40BA-31F6-4E2F-9E81-F6377C16A0A7Q27011565-CE488497-604B-451E-AE4C-84310909CCEEQ27025923-DFAFEE2D-A001-4BCB-B1AD-E9C5562028B8Q27026782-B4DEE1C5-3437-4787-BE5B-F83A89CD26A2Q28077015-26F0C8B3-2FCA-4967-9F34-E8FAD49EDE28Q28742438-5F340E92-7CDC-4E7A-A27B-B17AB2B61DFDQ28972322-CC0CA048-7111-4A74-B647-0770ADDCBBBEQ30277288-713E0318-F216-4FBE-B574-6F3B57FFA7C7Q30435321-97B22BD3-FD2A-4167-B669-1D9B8E968ACEQ30464036-2FAC4CAE-72A9-468C-A3D9-8E7BE730DC21Q33281822-B6EF1DC1-932A-4030-BD7A-0611A953A0E8Q33440958-730F4DE8-68B4-4209-B4AF-F8033AA62EEAQ33477846-29A771DE-623A-40E9-9808-41EA6F8D18C9Q33527737-BFD0BBD6-1FB2-4490-BC99-183D1859F778Q33552176-1977A743-CB65-4920-A944-D9B1DCA6BFD0Q33567772-5D2B655D-1ED6-49E2-8812-91F924CDA7E1Q33629743-AF1AD8E9-42A3-4534-A798-27764570AC9BQ33649463-BDC7BEC8-C754-4AAE-86F5-3A79A37E0833Q33650175-87739170-843C-45A5-BA6A-0F6B5C3B156BQ33656457-6A67F385-EA21-46E0-A4BD-E3750CAAA47FQ33684243-D20C2A4E-64E1-4837-84F9-EC2900875921Q33764453-821D1166-ADA4-40B2-8D64-BA3E13CC9B9FQ33781086-7D81723C-905B-4AF3-8FBA-A7654819472CQ33786496-32411434-CF8B-47D2-A820-93B46C8D67E1Q33795272-5F77D701-A9B3-4266-BEA1-14A2A6125226Q33812475-1FCEE0D5-AF47-4FF0-AC6E-0DCBF4762B37Q33846889-03FA4F1C-CDAD-476E-A77F-0E44321FA247Q33871325-DB21DA0E-C36F-45EC-9476-4BC9C9E5551AQ33897004-A1FF8F07-FB76-4566-975E-B46A5AB3D46FQ33933573-A53C7139-EC44-443C-BC97-C40AE89E164AQ33949054-9E50E98E-4C68-4347-A161-9865E90ABBA3Q33969311-99DA6705-F060-4AD9-98CB-E9FFF33FB6E5Q34000722-1FCB51A6-18A6-4732-9D4E-60B78D5FAE3A
P2860
Association of FMR1 repeat size with ovarian dysfunction.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Association of FMR1 repeat size with ovarian dysfunction.
@en
Association of FMR1 repeat size with ovarian dysfunction.
@nl
type
label
Association of FMR1 repeat size with ovarian dysfunction.
@en
Association of FMR1 repeat size with ovarian dysfunction.
@nl
prefLabel
Association of FMR1 repeat size with ovarian dysfunction.
@en
Association of FMR1 repeat size with ovarian dysfunction.
@nl
P2093
P2860
P356
P1433
P1476
Association of FMR1 repeat size with ovarian dysfunction.
@en
P2093
Epstein MP
Sherman SL
Sullivan AK
Yadav-Shah M
P2860
P304
P356
10.1093/HUMREP/DEH635
P407
P577
2004-12-17T00:00:00Z